Please leave this field empty
Facebook Twitter YouTube

In The News

Accordia Board Member Appointed New Chancellor of UCSF

May 7, 2009: Accordia Board Member Susan Desmond-Hellmann was approved is the next Chancellor of the University of California at San Francisco (UCSF) today by the UC Board of Regents. Desmond-Hellmann served as President of Product Development for Genetech until her resignation from that post earlier this week; she will join the university in her new position on August 3, 2009.

Reacting to the appointment, Accordia Global Health Foundation President Dr. Warner C. Greene said:

“Sue Hellmann was a founding member of the Accordia Global Health Foundation board of directors, and has served in that capacity with distinction since 2003. Her remarkable talents, skills, and intellect, honed over her career in private medical practice and then as an executive at two major pharmaceutical companies, are internationally respected and have served the global community well for decades.

“The University of California, San Francisco will benefit from Sue’s leadership and background as a creative thinker and strong leader. Accordia applauds the UCSF board of regents’ decision to make this appointment.”

Dr. Desmond-Hellmann has been long associated with UCSF, which is a world leader in training healthcare personnel and in health research. After finishing medical school at the University of Nevada at Reno, she completed her clinical training at UCSF and has served as an Assistant and Adjunct Professor of hematology-oncology. Of her new role, Desmond-Hellmann says, “I began my career at UCSF, and my heart has never left it… As the health needs of the world continue to change, UCSF will continue to play a pivotal role in developing solutions through its research, teaching and clinical care across all the health disciplines.”

Desmond-Hellmann leaves Genetech after fourteen years of serving in several capacities: as Clinical Scientist, Chief Medical Officer, Executive Vice President, and, most recently, as President of Product Development. Prior to moving to Genetech, she worked with Bristol-Myers Squibb’s Pharmaceutical Research Institute as Associate Director of Clinical Cancer Research. Earlier, during her nine years of training in internal medicine and oncology, Desmond-Hellmann spent two years as visiting faculty at the Uganda Cancer Institute studying AIDS and cancer.

 To the university, Desmond-Hellmann’s background provides strong clinical, research, and executive perspectives, as well as a deep commitment to quality care for patients. She will also be the first woman to serve as Chancellor for UCSF.

# # #

Accordia Global Health Foundation is a not-for-profit 501(c)(3) global health organization building Africa’s capacity to fight infectious disease through training, research, care and prevention. Accordia works in partnership with individuals, corporations, foundations, NGOs, and governments from Africa, Europe, and North America to achieve our vision of a healthier Africa. For more information please visit